Comparison Of In-Hospital Length Of Stay Between Patients Taking Rivaroxaban And Conventional Anticoagulants For Treatment Of Newly Diagnosed Venous Thromboembolism

被引：0
|
作者：
Desai, A. K. [1 ]
Desai, A. R. [1 ]
Aparnath, M. [1 ]
Calixte, R. [1 ]
Hindenberg, A. [1 ]
Mathew, J. P. [1 ]
机构：
[1] Winthrop Univ Hosp, Mineola, NY 11501 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
PULMONARY-EMBOLISM; ORAL RIVAROXABAN;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4871
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism
    Desai, Anish
    Desai, Amishi
    Calixte, Rose
    Aparnath, Malaygiri
    Hindenburg, Alexander
    Salzman, Steve
    Mathew, Joseph P.
    LUNG, 2016, 194 (04) : 605 - 611
  • [2] Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism
    Anish Desai
    Amishi Desai
    Rose Calixte
    Malaygiri Aparnath
    Alexander Hindenburg
    Steve Salzman
    Joseph P. Mathew
    Lung, 2016, 194 : 605 - 611
  • [3] COMPARISON OF RIVAROXABAN OR WARFARIN USE FOR VENOUS THROMBOEMBOLISM ON INPATIENT LENGTH OF STAY
    Deitelzweig, Steven
    Kline, Jeffrey
    Margolis, Jay M.
    Raut, Monika
    Tran, Oth
    Smith, David
    Crivera, Concetta
    Bookhart, Brahim
    Schein, Jeff
    Olson, William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2065 - 2065
  • [4] Comparison of hospital length of stay in patients treated with direct oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism.
    Saint, Catherine A.
    Castelli, Michelle R.
    Crannage, Andrew J.
    Stacy, Zachary A.
    Hennessey, Erin K.
    PHARMACOTHERAPY, 2016, 36 (12): : E239 - E239
  • [5] Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country
    Boietti, B.
    Fili, S.
    Peuchot, V.
    Tabares, A.
    Vazquez, F.
    Gandara, E.
    THROMBOSIS RESEARCH, 2021, 204 : 143 - 145
  • [6] Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism
    White, RH
    Zhou, H
    Romano, PS
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (09) : 1005 - 1010
  • [7] Reducing Hospital Length of Stay for Patients Newly Diagnosed with Acute Lymphoblastic Leukemia
    DiNofia, A.
    Wilkes, J.
    Flaherty, T.
    English, R.
    Sullivan, J.
    Oranges, K.
    Dwyer, E.
    Powell, S.
    Rheingold, S.
    Hunger, S. P.
    Reilly, A.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S173 - S174
  • [8] A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinoma
    Rastogi, Ashu
    Bhansali, Anil
    Dutta, Pinaki
    Singh, Paramjit
    Vijaivergiya, Rajesh
    Gupta, Vaishali
    Sachdeva, Naresh
    Bhadada, Sanjay Kumar
    Walia, Rama
    CLINICAL ENDOCRINOLOGY, 2013, 79 (03) : 409 - 415
  • [9] HOSPITAL LENGTH OF STAY AMONG VENOUS THROMBOEMBOLISM PATIENTS TREATED WITH APIXABAN AND WARFARIN IN ENGLAND
    Carroll, R.
    Lambrelli, D.
    Donaldson, R.
    Ramagopalan, S.
    Alikhan, R.
    VALUE IN HEALTH, 2019, 22 : S552 - S552
  • [10] COMPARISON OF TELEMEDICAL AND CONVENTIONAL TREATMENT OF HEART FAILURE PATIENTS CONSIDERING DIFFERENT APPROACHES TO IN-HOSPITAL STAY
    Lassnig, Alexander
    Schroettner, Joerg
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2013, 58
12345